Cargando…

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database

PURPOSE: Metastatic neuroendocrine tumors (mNETs) are rare, heterogeneous tumors that present diagnostic and treatment challenges, with limited data on the management of mNETs in clinical practice. The present study was designed to identify current diagnostic and treatment patterns in mNET patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fisher, Maxine D., Pulgar, Sonia, Kulke, Matthew H., Mirakhur, Beloo, Miller, Paul J., Walker, Mark S., Schwartzberg, Lee S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890585/ https://www.ncbi.nlm.nih.gov/pubmed/30121904 http://dx.doi.org/10.1007/s12029-018-0160-x

Ejemplares similares

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
por: Ortendahl, Jesse D, et al.
Publicado: (2017)

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors
por: Dromain, Clarisse, et al.
Publicado: (2021)

Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center
por: Jalbert, Jessica J., et al.
Publicado: (2020)

Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
por: Chan, Jennifer, et al.
Publicado: (2014)

PB2021: PHASE 2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH MAGROLIMAB FOR PREVIOUSLY UNTREATED SUBJECTS WITH INTERMEDIATE TO VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS)
por: Zeidan, Amer M., et al.
Publicado: (2023)

Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
por: Bowden, Michaela, et al.
Publicado: (2017)

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer
por: Chen, Li-Tzong, et al.
Publicado: (2019)

Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
por: Kulke, Matthew H, et al.
Publicado: (2011)

Metastatic neuroendocrine tumor masquerading as liver abscesses
por: Aggarwal, Abhimanyu, et al.
Publicado: (2020)

Living With Neuroendocrine Tumors: Assessment of Quality of Life Through a Mobile Application
por: Adams, Jared R., et al.
Publicado: (2019)

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial
por: Blot, Koenraad, et al.
Publicado: (2019)

Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
por: Fazio, Nicola, et al.
Publicado: (2021)

KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis
por: Carter, Gebra Cuyun, et al.
Publicado: (2015)

Report of metastatic ileal neuroendocrine tumor to the submandibular gland
por: Forner, David, et al.
Publicado: (2018)

Metastatic neuroendocrine pancreatic tumor – Case report
por: Radu, EC, et al.
Publicado: (2018)

Metastatic neuroendocrine tumor masquerading as orbital cysticercosis
por: Wirth, Magdalena A, et al.
Publicado: (2022)

Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
por: Ter‐Minassian, Monica, et al.
Publicado: (2017)

Neuroendocrine tumors in Panama: A nationwide database analysis
por: Cukier, Moises, et al.
Publicado: (2021)

Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study
por: Walker, Mark S., et al.
Publicado: (2017)

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis
por: Woodmansee, Whitney W., et al.
Publicado: (2018)

The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database
por: Wu, Zhengqi, et al.
Publicado: (2022)

Neuroendocrine Tumors: A Focus on Liver Metastatic Lesions
por: Limouris, Georgios S.
Publicado: (2012)

Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine Tumors
por: Lee, Eric, et al.
Publicado: (2012)

Metastatic Brain Neuroendocrine Tumor Originating from the Liver
por: Lee, Guk Jin, et al.
Publicado: (2015)

Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors
por: Debien, Véronique, et al.
Publicado: (2021)

Metastatic neuroendocrine tumors mimicking as primary ocular disease
por: Shen, Alice, et al.
Publicado: (2022)

FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
por: Lacombe, Caroline, et al.
Publicado: (2023)

Prognosis of patients with neuroendocrine tumor: a SEER database analysis
por: Man, Da, et al.
Publicado: (2018)

Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study
por: Paulson, Scott, et al.
Publicado: (2022)

FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate
por: Liu, Yiyan
Publicado: (2008)

A Case of Metastatic Gastric Neuroendocrine Tumor: Therapeutic Considerations
por: Kim, Shin Young, et al.
Publicado: (2014)

Right Ventricular Outflow Obstruction Due to Metastatic Neuroendocrine Tumor
por: Sood, Akhil, et al.
Publicado: (2018)

Case of an abnormal procalcitonin‐producing metastatic pancreatic neuroendocrine tumor
por: Wang, Wei‐Zhen, et al.
Publicado: (2020)

Metastatic Primary Neuroendocrine Tumor of Ovary—A Rare Presentation
por: Saha, Sanghamitra, et al.
Publicado: (2022)

Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration
por: Greenberg, Jacques, et al.
Publicado: (2022)

Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review
por: Williams, Jelani K., et al.
Publicado: (2023)

When is surgery indicated in metastatic small intestine neuroendocrine tumor?
por: Draskacheva, Nadica, et al.
Publicado: (2023)

Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients
por: Walker, Mark S, et al.
Publicado: (2011)

Safety of Polysorbate 80 in the Oncology Setting
por: Schwartzberg, Lee S., et al.
Publicado: (2018)

PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors
por: Fine, Gabriel C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m29dgth3tfum8boakotqibaa8t